Group 1 - The law firm Beijing DeHeng (Kunming) has provided legal opinions regarding the annual shareholders' meeting of Jianzhijia Pharmaceutical Chain Group Co., Ltd. [1] - The shareholders' meeting is scheduled for May 21, 2025, and the notice was published more than 20 days prior in various media outlets [2] - A total of 153 shareholders attended the meeting, representing 21,624,173 shares or 13.99% of the voting shares, while 147 shareholders participated via online voting, representing 60,662,057 shares or 39.25% of the voting shares [2] Group 2 - The meeting was presided over by Chairman Lan Bo and complied with legal and regulatory requirements [2] - The agenda included ten proposals, such as the 2024 annual financial report and the 2025 budget plan, which were approved through a combination of on-site and online voting [2] - The law firm concluded that the meeting's procedures, shareholder qualifications, and voting results were in accordance with legal standards and the company's articles of association [3]
健之佳: 北京德恒(昆明)律师事务所关于健之佳医药连锁集团股份有限公司2024年年度股东会的法律意见